GLAZER CAPITAL, LLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 1076809 New York, NY

Position in APGE

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$217,815,504

New position

Shares Held

1,641,042

first reported quarter

Ownership

2.17%

of shares outstanding

% of Portfolio

7.23%

of 13F equity value

Holder Rank

#10

of 285 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GLAZER CAPITAL, LLC holds $237,076,682 across 5 Biotechnology names. APGE ranks #1 (91.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc. This page	1,641,042	$217,815,504
2	TECH	BIO-TECHNE Corp	200,000	$14,130,000
3	TBPH	Theravance Biopharma, Inc.	301,834	$5,131,178
4	CPRX	Catalyst Pharmaceuticals, Inc.	3,602,865	$0
5	NUVL	Nuvalent, Inc.	1,769,665	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$217,815,504	1,641,042	—	Shares	Sole	2026-08-17
No filing history on record for this holder in this stock.